6 results found.

Gastroparesis Clinical Trial

Sheba Medical Center - Recruiting 18 years or older.
- Open Prospective Single Center Study for the Determination of Correlation Between Video Capsule Period of Retention in the Stomach and Symptoms of Gastroparesis.

Gastroparesis Clinical Trial using Haloperidol

The University of Texas Health Science Center, Houston - Recruiting 18 years to 90 years.
- Haloperidol vs Conventional Therapy for Gastroparesis.
Haloperidol

Gastroparesis Clinical Trial using GSK962040 (25 mg tablet); Placebo

GlaxoSmithKline - Recruiting 40 years to 80 years.
- A Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying.
GSK962040 (25 mg tablet); Placebo

Patients With Gastroparesis Who Have Failed Standard Therapy Clinical Trial using Domperidone

University of Iowa - Recruiting 18 years to 60 years.
- Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis.
Domperidone

Gastroparesis Clinical Trial using Sancusor

Temple University - Recruiting 18 years to 65 years.
- Sancusor in Patients With Nausea and/or Vomiting From Gastroparesis: An Open Label Study..
Sancusor

Functional Dyspepsia, or Diabetic Gastroparesis Clinical Trial using Magnetic Resonance Imaging MRI; Gamma Scintigraphy; Assessment of Gastric motor and sensory function

Nottingham University Hospitals NHS Trust - Recruiting 18 years to 80 years.
- Pilot Study: Assessment of Gastric Motor and Sensory Function to a Mixed Liquid and Solid Test Meal by Gamma Scintigraphy, Magnetic Resonance Imaging and a Nutrient Drink Test in Health and Patients With Disorders of Gastric Function.
Magnetic Resonance Imaging MRI; Gamma Scintigraphy; Assessment of Gastric motor and sensory function